Julie Berg's life revolves around three things: family, friends and faith. The 79-year-old has a large extended family that enjoys celebrating large and small milestones together, and she has a wide network of close-knit friends across two states. Through it all, her strong Catholic faith has been the foundation of her life. When Julie's health was tested, she leaned on her family, friends and faith for support.
Mayo Clinic in Rochester will offer COVID-19 walk-in vaccine clinics for patients, visitors and community members the week of Monday, Oct. 4.
Since the beginning of the COVID-19 pandemic, health care professionals have worked hard to develop treatments for patients, and they have learned to manage the risk of hospitalization and death from COVID-19.
The speed was a result of many pharmaceutical companies simultaneously investing significant resources into quickly developing a vaccine because of the world-wide impact of the pandemic. The emergency situation warranted an emergency response, but that does not mean that companies bypassed safety protocols or adequate testing.
COVID-19 hospitalizations in the U.S. are reportedly dropping. While the news headlines are encouraging, the country is in its fourth surge heading into flu season and winter holidays. That is why medical experts are keeping their predictions and recommendations fluid. How the virus spreads depends on human behavior.
DEAR MAYO CLINIC: I've heard several drugs mentioned as possible treatments for COVID-19. What are they, and how do they work?
ANSWER: Since the COVID-19 pandemic began, finding an effective drug to combat COVID-19 has been on the minds of many. While many medications are being tested to treat COVID-19, only one has been approved by the Food and Drug Administration (FDA).
On Thursday, Oct. 7, Dr. Greg Vanichkachorn, a Mayo Clinic occupational medicine specialist, discussed how for some patients, post-COVID syndrome is becoming a chronic condition. Dr. Vanichkachorn shared recent research findings, offered tips on how people can protect themselves from developing post-COVID syndrome and answered journalists' questions.